SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations
Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Jul 12, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations" is studying a tool called the Canadian Syncope Risk Score (CSRS) to help emergency department (ED) doctors make better decisions when patients come in after experiencing syncope, which is a temporary loss of consciousness. This trial aims to see if using the CSRS can reduce unnecessary hospital admissions and shorten the time patients spend in the ED, while still keeping them safe. By applying the CSRS recommendations, the researchers believe that only a small percentage of high-risk patients will need to be admitted to the hospital, and that many low-risk patients can be safely discharged more quickly.
To be eligible for this trial, adults over the age of 18 who come to the ED within 24 hours of experiencing syncope may participate. However, patients who have certain conditions or situations, such as a prolonged loss of consciousness or a clear seizure before the fainting episode, will not be included. Participants can expect that their care will be guided by the CSRS recommendations, which could lead to a more efficient and safer experience in the ED. This trial is currently recruiting participants and aims to involve several EDs across Canada to test how well the CSRS works in real-life settings.
Gender
ALL
Eligibility criteria
- Physicians:
- Inclusion criteria:
- • ED physicians involved in ED syncope care
- • Non-ED physicians involved in ED syncope care
- • Physician's delegates involved in ED syncope care
- Exclusion criteria:
- • ED physicians not involved in ED syncope care
- • Non-ED physicians not involved in ED syncope care
- • Physician's delegates not involved in ED syncope care
- Patients:
- Inclusion criteria:
- • Patients who are adults (aged \> 18 years)
- • Patients who present to the ED within 24 hours of syncope.
- Exclusion criteria:
- • Patients who do not fulfill the definition of syncope, namely those with a prolonged loss of consciousness (i.e., \> 5 minutes), Glasgow Coma Scale \< 15 in patients without dementia (or a change in the mental status from baseline in those with dementia);
- • Patients with witnessed obvious seizure, or head trauma preceding the loss of consciousness; and those who are unable to provide proper details (e.g., alcohol intoxication or other substance use).
- • Patients who had a serious underlying for the syncope identified during the index ED evaluation and those who were consulted to an inpatient service or hospitalized for reasons other than syncope workup (e.g., social reasons such as inability to cope at home, pain due to the fall, significant trauma).
About Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
London, Ontario, Canada
Calgary, Alberta, Canada
Toronto, Ontario, Canada
Winnipeg, Manitoba, Canada
Winchester, Ontario, Canada
Montréal, Quebec, Canada
Montréal, Quebec, Canada
Québec, Quebec, Canada
Sudbury, Ontario, Canada
Thunder Bay, Ontario, Canada
Montréal, Quebec, Canada
Hawkesbury, Ontario, Canada
North Bay, Ontario, Canada
Welland, Ontario, Canada
Quebec, , Canada
Quebec, , Canada
Patients applied
Trial Officials
Venkatesh Thiruganasambandamoorthy, CCFP-EM, MSc
Principal Investigator
Ottawa Hospital Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials